| Literature DB >> 32642146 |
Chalerm Liwsrisakun1, Chaicharn Pothirat1, Warawut Chaiwong1, Tanagorn Techatawepisarn1, Atikun Limsukon1, Chaiwat Bumroongkit1, Athavudh Deesomchok1, Theerakorn Theerakittikul1, Pattraporn Tajarernmuang1.
Abstract
BACKGROUND: Balance assessment is now recommended by clinical practice guidelines, specific tests have yet to be suggested. The Timed Up and Go (TUG) test is a simple measure of balance status and functional mobility. Nowadays, we need more data of an optimum cut off point of TUG time for detecting balance impairment in patients with chronic obstructive pulmonary disease (COPD). Thus the aim of this study was to evaluate the diagnostic ability relative to balance impairment of the TUG in subjects with COPD.Entities:
Keywords: Chronic obstructive pulmonary disease (COPD); balance; falls; movement; validity
Year: 2020 PMID: 32642146 PMCID: PMC7330337 DOI: 10.21037/jtd.2020.03.47
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895
Figure 1Flow-chart describing the study population. COPD, chronic obstructive pulmonary disease.
Demographics of smoking related COPD patients with and without balance impairment
| Characteristics | Balance impairment (n=24) | Non-Balance impairment (n=94) | P value |
|---|---|---|---|
| Age (median, IQR) | 81.0 (73.5–85.3) | 72.0 (65.0–78.3) | <0.001 |
| Sex (male) | 9 (37.5) | 77 (81.9) | <0.001 |
| BMI (kg/m2) (median, IQR) | 19.2 (15.5–21.4) | 21.3 (18.5–24.0) | 0.025 |
| Spirometry results (median, IQR) | |||
| Post-bronchodilator FEV1/FVC | 59.9 (49.0–65.8) | 55.3 (47.6–62.1) | 0.275 |
| Post-bronchodilator FVC (%) | 76.6 (55.7–85.4) | 83.6 (69.2–100.1) | 0.039 |
| Post-bronchodilator FEV1 (%) | 57.5 (36.9–68.9) | 60.3 (44.9–70.4) | 0.377 |
| SGRQ total score (median, IQR) | 44.5 (35.7–55.3) | 37.8 (16.9–53.2) | 0.036 |
| CAT score (median, IQR) | 14.0 (11.3–19.3) | 9.0 (5.0–15.3) | 0.002 |
| mMRC scale, median (IQR) | 3.0 (2.3–3.0) | 2.0 (1.0–2.0) | <0.001 |
| TUG (second) (median, IQR) | 15.7 (13.8–18.8) | 9.1 (7.8–10.8) | <0.001 |
| 6-MWD (meter) (median, IQR) | 131.0 (68.0–232.3) | 345.0 (289.8–420.0) | <0.001 |
| Berg Balance score (median, IQR) | 37.5 (32.0–41.8) | 53.0 (49.0–55.0) | <0.001 |
| Percent of Berg Balance Score =56 points | 0 (0.0) | 9 (9.6) | 0.201 |
| History of fall in the previous year | 4 (16.7) | 2 (2.1) | 0.047 |
| History of AECOPD in the previous year | 8 (33.3) | 20 (21.3) | 0.274 |
| Impaired visualization | 4 (16.7) | 8 (8.5) | 0.261 |
| GOLD classification | 0.057 | ||
| A | 2 (8.3) | 30 (31.9) | |
| B | 9 (37.5) | 25 (26.6) | |
| C | 0 (0.0) | 5 (5.3) | |
| D | 13 (54.2) | 34 (36.2) | |
| Inhaled COPD medication | 0.820 | ||
| LABA or LAAC | 5 (20.8) | 20 (21.2) | |
| Combination of ICS and LABA | 9 (37.5) | 37 (39.4) | |
| Triple therapy (ICS + LABA + LAAC) | 10 (41.7) | 37 (39.4) | |
| Cardiovascular disease comorbidities | 8 (33.3) | 27 (28.7) | 0.803 |
| LTOT used | 3 (12.5) | 6 (6.4) | 0.385 |
| Anxiety | 1 (4.2) | 2 (2.1) | 0.498 |
| Depression | 4 (16.7) | 6 (6.4) | 0.117 |
| Gait aids used | 6 (25.0) | 0 (0.0) | <0.001 |
6-MWD, six-minute walk distance; AECOPD, acute exacerbation of chronic obstructive pulmonary disease; BMI, body mass index; CAT, COPD Assessment Test; FEV1, forced expiratory volume in first second; FVC, forced vital capacity; GOLD, Global Initiative for Chronic Obstructive Lung Disease; ICS, inhaled corticosteroids; IQR, Inter quartile range; LAAC, long acting anticholinergic; LABA, long acting beta2-agonists; LTOT, long term oxygen therapy; mMRC, modified Medical Research Council; SGRQ, St. George’s Respiratory Questionnaire; TUG, Timed Up and Go.
Discriminative property TUG cut-off points for balance impairment in smoking related COPD
| TUG cut-off (second) | Sensitivity (%) | Specificity (%) | LR+ | LR− | AUROC | Youden’s index |
|---|---|---|---|---|---|---|
| ≥10.0 | 100.0 | 60.6 | 2.54 | 0.00 | 0.80 | 60.6 |
| ≥10.5 | 100.0 | 70.2 | 3.36 | 0.00 | 0.85 | 70.2 |
| ≥11.0 | 95.8 | 76.6 | 4.09 | 0.05 | 0.86 | 72.4 |
| ≥11.5 | 95.8 | 83.0 | 5.63 | 0.05 | 0.89 | 78.8 |
| ≥12.0 | 95.8 | 90.4 | 10.01 | 0.05 | 0.93 | 86.2 |
| ≥12.5 | 87.5 | 90.4 | 9.14 | 0.14 | 0.89 | 77.9 |
| ≥13.0 | 79.2 | 93.6 | 10.63 | 0.23 | 0.86 | 72.8 |
| ≥13.5 | 79.2 | 93.6 | 12.40 | 0.22 | 0.86 | 72.8 |
| ≥14.0 | 75.0 | 95.7 | 17.63 | 0.26 | 0.85 | 70.7 |
| ≥14.5 | 66.7 | 96.8 | 20.89 | 0.34 | 0.82 | 63.5 |
| ≥15.0 | 58.3 | 98.9 | 54.83 | 0.42 | 0.79 | 57.2 |
| ≥15.5 | 54.2 | 98.9 | 50.92 | 0.46 | 0.77 | 53.1 |
| ≥16.0 | 45.8 | 98.9 | 43.08 | 0.55 | 0.72 | 44.7 |
| ≥16.5 | 41.7 | 98.9 | 39.17 | 0.59 | 0.70 | 40.6 |
| ≥17.0 | 39.2 | 98.9 | 39.17 | 0.59 | 0.70 | 38.1 |
AUROC, area under receiver operating characteristic curve; COPD, chronic obstructive pulmonary disease; LR+, positive likelihood ratio; LR−, negative likelihood ratio; TUG, Timed Up and Go.
Figure 2Receiver operating curve of the TUG for detecting balance impairment in smoking related COPD patients. COPD, chronic obstructive pulmonary disease; ROC, receiver operating characteristic curve; TUG, Timed Up and Go.
Multivariable analysis for identifying the TUG ≥12 seconds as a predictor for balance impairment in COPD patients
| Risk factors | Adjusted risk ratio | 95% CI | P value |
|---|---|---|---|
| TUG ≥12 seconds | 25.2 | 1.6–312.0 | 0.021 |
| 6-MWD <300 meters | 3.1 | 0.4–28.0 | 0.303 |
| Cardiovascular co-morbidity | 1.8 | 1.0–3.2 | 0.043 |
| Sex: female | 1.5 | 0.8–2.6 | 0.186 |
| History of falling in the previous year | 1.3 | 0.9–1.9 | 0.171 |
| BMI <18.5 kg/m2 | 1.3 | 0.9–1.9 | 0.163 |
| Age ≥70 years | 1.2 | 0.7–2.0 | 0.520 |
| Impaired visualization | 1.1 | 0.6–1.8 | 0.776 |
| Marital status: married | 0.9 | 0.6–1.5 | 0.838 |
6-MWD, six-minute walk distance; BMI, body mass index; CI, confidence interval; COPD, chronic obstructive pulmonary disease; TUG, Timed Up and Go.
Figure 3ROC of the TUG ≥12 second form multivariate analysis for detecting balance impairment in COPD patients. COPD, chronic obstructive pulmonary disease; ROC, receiver operating characteristic curve; TUG, Timed Up and Go.